Cha Biotech cuts vaccine stake, bets on CGT, AI

Cha Biotech said Thursday it will transfer 8.95 million shares in Cha Vaccine Institute, worth 23.8 billion won ($15.8 million), to Solux, AriBio Investment Purpose No. 13 and other investors.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.